Literature DB >> 5131599

The role of the interferon system in respiratory syncytial virus infections.

J M Moehring, B R Forsyth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5131599     DOI: 10.3181/00379727-138-36039

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  8 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Production of interferon in respiratory syncytial virus bronchiolitis.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

3.  Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a.

Authors:  R Y Sung; J Yin; S J Oppenheimer; J S Tam; J Lau
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

4.  Defective interfering particles of respiratory syncytial virus.

Authors:  M W Treuhaft; M O Beem
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

5.  Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses.

Authors:  T Chonmaitree; N J Roberts; R G Douglas; C B Hall; R L Simons
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

6.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Antiviral effects of bovine interferons on bovine respiratory tract viruses.

Authors:  R W Fulton; M M Downing; J M Cummins
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

8.  The efficacy of intranasal interferon alpha-2a in respiratory syncytial virus infection in volunteers.

Authors:  P G Higgins; G I Barrow; D A Tyrrell; D Isaacs; C L Gauci
Journal:  Antiviral Res       Date:  1990-07       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.